BEGIN:VCALENDAR
VERSION:2.0 
PRODID:-/-/EN
BEGIN:VEVENT
SUMMARY:Liquid biopsy in the NHS - present and future
UID:1204
DESCRIPTION:To book for or join this event please use this link: https://mms.org.uk/events/1204/liquid_biopsy_in_the_nhs_-_present_and_future/webinar?dr=1256\n\nYou will be able to submit questions to the speaker during the event using the Q&A function on Zoom. \n\n1.00 - 2.00 pm\n\nDr Matthew Krebs, Clinical Senior Lecturer in Experimental Cancer Medicine,  The University of Manchester and Consultant Medical Oncologist at The Christie NHS Foundation Trust\n\nTalk synopsis:\n\nLiquid biopsy enables faster turnaround time for genomic results that are increasingly required to aid diagnosis and treatment selection in patients with cancer and identify clinical trial opportunities. This talk will cover steps the NHS have been taking to implement ctDNA testing in routine care, how this is delivered and specifically \n\nImpact of introducing testing in lung and breast cancer patients as exemplars, challenges and lessons learned Future direction with new liquid biopsy indications and potential for impactRole of the circulating biomarker Network of Excellence in standardising an approach to liquid biopsy implementation  \n\nCPD Certificates will be awarded to attendees\n\n
DTSTART:20260311T130000Z
DTEND:20260311T140000Z
LOCATION:ZOOM
LOCATION:https://mms.org.uk/events/1204/liquid_biopsy_in_the_nhs_-_present_and_future?dr=1256
END:VEVENT
END:VCALENDAR